Search
Returning search results with filters:
Remove filter for
Audience: Health professionals
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2020
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2020
- December 20204 results available
- November 20201 results available
- October 20206 results available
- September 20205 results available
- August 20201 results available
- July 20204 results available
- June 20202 results available
- May 20207 results available
- April 20206 results available
- March 20202 results available
Displaying 16 - 30 of 38 items.
ESBRIET (pirfenidone) and the Risk of Drug-Induced Liver Injury
AlertHealth professional risk communication | 2020-09-14
Prescription Cough and Cold Products Containing Opioids and the Risk of Opioid Use Disorder in Children and Adolescents (< 18 years of age)
AlertHealth professional risk communication | 2020-08-24
Non-prescription pain relief products containing codeine are not recommended for use in people under 18 years of age
AlertPublic advisory | 2020-07-31
Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms
AlertPublic advisory | 2020-07-28
Methadone Treatment of Opioid Dependence and Potential Risk of Lack of Effect when Switching between Different Products
AlertHealth professional risk communication | 2020-07-17
Information Update - Use of the drug Picato may increase the risk of skin cancer
AlertInformation update | 2020-07-02
NARDIL (phenelzine sulfate) Shortage
AlertHealth professional risk communication | 2020-06-24
MabCampath (alemtuzumab) - Risk of Haemophagocytic Lymphohistiocytosis, Stroke (including ischaemic and haemorrhagic stroke), and Glomerulonephritis
AlertHealth professional risk communication | 2020-06-22
Importation of US-Labelled Rocuronium Bromide Injection Due to Shortage of Canadian-labelled Rocuronium
AlertHealth professional risk communication | 2020-05-25
Cisatracurium Omega Multi-Dose (Cisatracurium Besylate Injection): Temporary change of ferrule (metal seal) colour to maintain continued supply in Canada
AlertHealth professional risk communication | 2020-05-25
Importation of US-Labelled Rocuronium Bromide Injection distributed by Avir Pharma Inc. Due to Shortage of Canadian-labelled Rocuronium
AlertHealth professional risk communication | 2020-05-25
Importation of Fresenius Propoven 2% due to Shortage of Canadian Labelled Propofol Injection 1% Products
AlertHealth professional risk communication | 2020-05-19
Importation of Spanish-Labelled Salbutamol Aldo-Union inhalers due to Shortage of Canadian-Labelled Salbutamol
AlertHealth professional risk communication | 2020-05-19
Important Safety Information - Importation of Teva UK-labelled Salamol CFC-Free (Salbutamol Sulfate) Inhaler due to Shortage
AlertHealth professional risk communication | 2020-05-13
Importation of US-Labelled Ketamine Hydrochloride for Injection due to Potential Shortage of Canadian-labelled Ketamine
AlertHealth professional risk communication | 2020-05-06